| 2019 | S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
| CANCER RESEARCH AND TREATMENT |
| 2013 | S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial
| BMC CANCER |
| 2008 | S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2020 | S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial | LANCET ONCOLOGY |
| 2021 | Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors | CLINICAL CANCER RESEARCH |
| 2021 | Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial | CLINICAL CANCER RESEARCH |
| 2020 | Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
| CLINICAL CANCER RESEARCH |
| 2022 | Safety and efficacy of HER2 blockade by trastuzumab-based chemotherapy-containing combination strategies in HER2+ gastroesophageal adenocarcinoma
| ESMO OPEN |
| 2020 | Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric Cancer
| CLINICAL CANCER RESEARCH |
| 2011 | Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
| CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2024 | Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study | GASTRIC CANCER |
| 1996 | Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression | CLINICAL & EXPERIMENTAL METASTASIS |
| 1997 | Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression | BREAST CANCER RESEARCH AND TREATMENT |
| 2006 | Severe Hypothyroidism Induced by Thyroid Metastasis of Colon Adenocarcinoma: A Case Report and Review of the Literature
| ENDOCRINE JOURNAL |
| 2006 | Significant Gene Selection Using Integrated Microarray Data Set with Batch Effect
| Genomics & Informatics |
| 2008 | Standardization of the Korean version of Mini-Mental Adjustment to Cancer (K-Mini-MAC) scale: factor structure, reliability and validity | PSYCHO-ONCOLOGY |
| 2009 | Standardized genetic alteration score and predicted score for predicting recurrence status of gastric cancer | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2004 | Statistical methods of determining a cut off value between normal and disease groups
| Bulletin of Informatics and Cybernetics |
| 2018 | Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 2009 | Subtelomeric DNA methylation and telomere length in human cancer cells | CANCER LETTERS |
| 2011 | Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles. | ONCOLOGY |
| 2014 | Sunitinib in metastatic renal cell carcinoma: An ethnic Asian subpopulation analysis for safety and efficacy | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 2013 | Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial | JOURNAL OF CLINICAL ONCOLOGY |
| 2002 | Suppression of peritoneal metastasis by expression of murine endostatin cDNA
| CANCER RESEARCH AND TREATMENT |
| 2008 | Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases
| ANNALS OF ONCOLOGY |
| 2004 | Synchronous Coexpression of Epidermal Growth Factor Receptor and Cyclooxygenase-2 in Carcinomas of the Uterine Cervix - A Potential Predictor of Poor Survival
| CLINICAL CANCER RESEARCH |
| 1998 | Synchronous elevation of soluble intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) correlates with gastric cancer progression
| YONSEI MEDICAL JOURNAL |
| 2006 | Systematic analysis of cDNA microarray-based CGH. | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 1998 | Telomerase Activity and Telomere Lengths in Various Cell Lines: Changes of Telomerase Activity Can Be Another Method for Chemosensitivity Evaluation | INTERNATIONAL JOURNAL OF ONCOLOGY |
| 2013 | Telomerase- and angiogenesis-related gene responses to irradiation in human umbilical vein endothelial cells | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 2019 | Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
| CANCER RESEARCH AND TREATMENT |
| 2010 | The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up | ANNALS OF SURGICAL ONCOLOGY |
| 2010 | The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2015 | The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2008 | The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2014 | The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression. | MOLECULAR CANCER THERAPEUTICS |
| 2009 | The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer | JOURNAL OF SURGICAL ONCOLOGY |
| 2015 | The Impact of Coping Styles on Psychological Distress and Quality of Life in Korean Patients with Cancer
| Korean Journal of Psycho-Oncology (정신종양학회지) |
| 2021 | The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
| NATURE |
| 2004 | The pattern of gene copy number changes in bilateral breast cancer surveyed by cDNA microarray-based comparative genomic hybridization. | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 2018 | The prognostic value of volume-based parameters using<sup>18</sup>F-FDG PET/CT in gastric cancer according to HER2 status | GASTRIC CANCER |
| 2001 | The significance of granzyme B expression in patients with angiocentric lymphoma of the head and neck | CANCER |
| 2013 | Therapeutic Strategies for Well-differentiated Papillary Mesothelioma of the Peritoneum
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2000 | Tissue urokinase-type plasminogen activator receptor levels in breast cancer | International Journal of Molecular Medicine |
| 2020 | Transcriptome analysis of iBET-151, a BET inhibitor alone and in combination with paclitaxel in gastric cancer cells
| Genomics & Informatics |
| 2023 | Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction Cancer | JOURNAL OF CLINICAL ONCOLOGY |
| 2022 | Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-positive advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: Final overall survival (OS) results from a randomized, multicenter, open-label, phase 2 study (DESTINY-Gastric01) | JOURNAL OF CLINICAL ONCOLOGY |
| 2023 | Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial
| JOURNAL OF CLINICAL ONCOLOGY |
| 2020 | Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer | NEW ENGLAND JOURNAL OF MEDICINE |
| 2017 | Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study | LANCET ONCOLOGY |
| 2010 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. | LANCET |
| 2002 | Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy. | BRITISH JOURNAL OF SURGERY |
| 2011 | Treatment of recurrent hepatocellular carcinoma after liver transplantation | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 2009 | Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in Korea
| CANCER RESEARCH AND TREATMENT |
| 2022 | Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors
| CANCERS |
| 2004 | Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus | CANCER GENE THERAPY |
| 2010 | Two dosages of oral fluoropyrimidine S-1 of 35 and 40 mg/m2 bid: comparison of the pharmacokinetic profiles in Korean patients with advanced gastric cancer
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2008 | Variation of the 3' telomeric overhang lengths in human cells | CANCER LETTERS |
| 2020 | Waun Ki Hong, MD, D.M.Sc (Hon) (1942-2019): A Mentor Who Left Behind a Legacy for Generations to Come
| YONSEI MEDICAL JOURNAL |
| 2007 | Whole genome analysis for liver metastasis gene signatures in colorectal cancer | INTERNATIONAL JOURNAL OF CANCER |
